To fund promising research to find a cure for Appendix Cancer and Pseudomyxoma Peritonei (PMP), and to fund and support educational programs for healthcare professionals, patients, caregivers, and family members about these diseases.
(acpmp)appendix Cancerpseudomyxoma Peritonei Research Foundation centers its giving on appendix cancer and pseudomyxoma peritonei, with research awards that range from $25,000 investigator grants to $150,000 Changemaker awards. The foundation also supports educational programs for healthcare professionals, patients, caregivers, and family members affected by these diseases. Recent grants show a research-heavy approach: University of California, Irvine received $100,000 for research, while multiple medical centers and university-based investigators received $25,000 awards for appendix cancer and PMP studies. The pattern suggests a funder focused on scientific, clinical, and translational work rather than broad cancer philanthropy. Its grant programs include awards administered through the Society of Surgical Oncology, direct research grants, and travel support for conference presentation. The funded projects address appendiceal mucinous neoplasms, appendiceal adenocarcinomas, molecular characterization, tumor microenvironment, and model development. That mix places the foundation squarely in disease-specific rare cancer research, with an emphasis on work that can change understanding of diagnosis and treatment for patients with appendix cancer and PMP.
In appendix cancer research, the foundation funded $100,000 to University of CA Irvine Dr Oliver Eng for research, alongside $25,000 grants to University of California Dr Andrew Lowy and Dr Shen U of Texas MD Anderson Cancer Ctr for additional research. These awards point to a strong clinical and translational orientation. For pseudomyxoma peritonei, the foundation supports projects aimed at appendiceal origin disease, including studies on molecular characterization, the tumor microenvironment, and prospective investigations and trials. It also backs early detection and diagnosis work through its Catalyst Research Grant program. Education is another stated area: the foundation supports programs for healthcare professionals, patients, caregivers, and family members about appendix cancer and PMP. It also funds travel awards for presenters attending the SSO ACT Conference, tying research support to dissemination.
$250K
$2.2M
$764K
$606K
Most grants fall between $25K and $25K, with a median of $25K.
25th Percentile
$25K
Median
$25K
75th Percentile
$25K
About 14% of grants go to recipients in CA.
JAMES CARROLL
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Typical grant size is $25,000 at the median, with p25 and p75 also both at $25,000, showing a cluster of standard awards at that level. The recent grant list also includes one $100,000 award, indicating some larger project support alongside the smaller investigator grants. The foundation’s annual grants total $250,000 against assets of $2,218,027. Several programs are unsolicited, including the Lisa Kurtz Luciano Appendix Cancer and PMP Clinical Investigator Award, the $150,000 Changemaker Research Grant, the ACPMP / NORD Research Grants, the ACPMP Research Foundation Changemaker Grant, and the ACPMP-funded Young Investigator Award. Other programs are not open to unsolicited applications. The recent grant pattern is concentrated in research awards rather than recurring operating support.
Grantmaking is national in scope, and all recent grants in the sample went to recipients in the United States. Texas is the top state by grant count, with a recent award to Dr Shen U of Texas MD Anderson Cancer Ctr in Houston. Other recent recipient locations include Orange and San Diego, California; Birmingham, Alabama; Pittsburgh, Pennsylvania; New York, New York; and Duarte, California. Pennsylvania accounts for 14% of grants in the data, reflecting some in-state giving alongside broader national distribution.
It funds promising research to find a cure for appendix cancer and pseudomyxoma peritonei, plus educational programs for healthcare professionals, patients, caregivers, and family members. The active programs also support clinical, translational, basic scientific, and conference-presentation travel awards.
The typical award is $25,000, with p25, median, and p75 all at $25,000. The recent grant data also includes a larger $100,000 award, showing that the foundation sometimes supports higher-cost research projects.
Yes. Several active programs accept unsolicited applications, including the Lisa Kurtz Luciano Appendix Cancer and PMP Clinical Investigator Award, the $150,000 Changemaker Research Grant, the ACPMP / NORD Research Grants, the ACPMP Research Foundation Changemaker Grant, and the ACPMP-funded Young Investigator Award.
Its giving is national, and the recent grants data shows all grants went to U.S. recipients. Recent recipients were located in California, Alabama, Texas, Pennsylvania, and New York, with Texas the top state by grant count.
Yes. Its stated purpose includes funding research on appendix cancer and PMP as well as educational programs for healthcare professionals, patients, caregivers, and family members. The active programs also include travel awards tied to research presentation.
2025
Source: IRS Form 990-PF, fiscal year 2025.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| UNIVERSITY OF CA IRVINE - DR OLIVER ENG | ORANGE, CA | $100,000 | 2026 | RESEARCH |
| NATIONAL ORGANIZATION FOR RARE DISORDERS INC | QUINCY, MA | $100,000 | 2026 | RESEARCH |
| UNIVERSITY OF ALABAMA - DR KIMBERLY KOPECKY | TUSCALOOSA, AL | $25,000 | 2026 | RESEARCH |
| AHN RESEARCH INSTITUTE - DR PATRICK WAGNER | PITTSBURGH, PA | $25,000 | 2026 | RESEARCH |
| U OF TEXAS MD ANDERSON CANCER CTR - DR JOHN PAUL SHEN | HOUSTON, TX | $25,000 | 2026 | RESEARCH |
| THE SOCIETY OF SURGICAL ONCOLOGY INC | ROSEMONT, IL | $15,500 | 2026 | EDUCATION |
| UNIVERSITY OF CA IRVINE | ORANGE, CA | $100,000 | 2025 | RESEARCH |
| UNIVERSITY OF CALIFORNIA | SAN DIEGO, CA | $25,000 | 2025 | RESEARCH |
| MEMORIAL SLOAN KETTERING CANCER CTR | NEW YORK, NY | $25,000 | 2025 | RESEARCH |
| UNIVERSITY OF ALABAMA BIRMINGHAM | BIRMINGHAM, AL | $25,000 | 2025 | RESEARCH |
| AHN REASEARCH INSTITUTE | PITTSBURG, PA | $25,000 | 2025 | RESEARCH |
| DR SHEN | HOUSTON, TX | $25,000 | 2025 | RESEARCH |
| CITY OF HOPE | DUARTE, CA | $25,000 | 2025 | RESEARCH |
| MEMORIAL SLOAN KETTERING CANCER CTR | NEW YORK, NY | $25,000 | 2024 | RESEARCH |
| MOFITFIT CANCER CENTER | WINSTONSALEM, NC | $50,000 | 2023 | RESEARCH |
| VANDERBILT UNIVERSITY MEDICAL CTR | NASHVILLE, TN | $25,000 | 2023 | RESEARCH |
UNIVERSITY OF ALABAMA - DR KIMBERLY KOPECKY
$25,000RESEARCH
AHN RESEARCH INSTITUTE - DR PATRICK WAGNER
$25,000RESEARCH
U OF TEXAS MD ANDERSON CANCER CTR - DR JOHN PAUL SHEN
$25,000RESEARCH
THE SOCIETY OF SURGICAL ONCOLOGY INC
$15,500EDUCATION
MEMORIAL SLOAN KETTERING CANCER CTR
$25,000RESEARCH
UNIVERSITY OF ALABAMA BIRMINGHAM
$25,000RESEARCH
AHN REASEARCH INSTITUTE
$25,000RESEARCH
DR SHEN
$25,000RESEARCH
MEMORIAL SLOAN KETTERING CANCER CTR
$25,000RESEARCH